Lung infection study in ICU patients
Part of Infections, Lungs & breathing clinical trials.
This trial tests a new way to better understand lung infections in very sick ICU patients. It looks at people with septic shock, severe trauma, or major burns to see if an infection is the cause.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are in the ICU with one of the following: septic shock from pneumonia or another source, severe trauma (Injury Severity Score 25 or more), or burns covering more than 20% of your body.
- You are on a vasopressor medication (like norepinephrine) at a dose of 0.1 micrograms per kilogram per minute or higher.
- You have at least two organ systems that are failing (based on the SOFA score of 2 or more points each).
- You are not taking strong immune-suppressing drugs, have HIV, or have had cancer treatment in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using a rapid test to find the exact bacteria causing your pneumonia can help doctors choose the right antibiotics faster, which might improve your recovery. The study compares this approach to usual care in patients on ventilators.
This study looks at different types of lung infections in ICU patients on breathing machines. By analyzing fluid from your lungs, researchers hope to better understand pneumonia and improve treatment.
This study watches patients in the intensive care unit (ICU) who are on a breathing machine (ventilator) to learn more about pneumonia that can happen from the machine. The goal is to understand how to better prevent and treat this infection.
This study looks at how the immune system reacts in ICU patients on a ventilator who have pneumonia. By measuring immune markers, the researchers hope to better understand and predict complications like ventilator-associated pneumonia.
This trial tests whether breathing in special viruses (called phages) that attack the Pseudomonas bacteria can help clear a serious lung infection in patients on ventilators. The treatment is added to standard antibiotics and may help fight the infection better.
This trial tests an “antibiotic stewardship” approach—choosing and adjusting antibiotics in a smarter way—for a first episode of pneumonia in patients on a breathing machine. It may help ensure the right antibiotics are used at the right time, while avoiding unnecessary or overly broad treatment.
Hear when a new VAP - Ventilator Associated Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.